Alopecia Areata
📧 Sign up to get email alerts when something new happens for Alopecia Areata.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: CorEvitas Alopecia Areata (AA) Safety and Effectiveness Registry
A ClinicalTrials.gov listing shows the CorEvitas Alopecia Areata Safety and Effectiveness Registry is currently recruiting to assess safety …
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: PALLAS Laser for Skin Diseases [NA]
A clinical trial update indicating recruitment for a study evaluating the PALLAS Laser for skin diseases, including vitiligo, psoriasis, alo…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Treatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down Syndrome [Phase 2]
A Phase 2 clinical trial is evaluating abrocitinib for atopic dermatitis and alopecia areata in individuals with Down syndrome and is curren…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Cyclosporine Or Methotrexate for Pediatric Alopecia Areata: Routine Clinical Care Effectiveness Study [Phase 4]
A Phase 4 pediatric trial evaluating the effectiveness of cyclosporine or methotrexate for alopecia areata, currently recruiting in routine …
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata [Phase 3]
Sun Pharmaceutical's study is a Phase 3 trial evaluating the efficacy and safety of deuruxolitinib in adolescents with severe alopecia areat…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-01-26Clinical Trial Update: DPCP for the Treatment of Alopecia Areata [Phase 3]
Phase 3 trial of Diphenylcyclopropenone (DPCP) for alopecia areata was terminated, with results posted on 2026-01-26.
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: Combined Microneedling With Either 1% Lactic Acid Solution or Vitamin D3 or Triamcinolone Acetonide in The Treatment of Alopecia Areata [NA]
A clinical trial from Zagazig University is evaluating microneedling combined with either 1% lactic acid, vitamin D3 (cholecalciferol), or t…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: LANDSCAPE: Demographics and Treatment Patterns of Patients With Immune-Mediated Inflammatory Skin Diseases in Italian Clinical Practice
The LANDSCAPE study, sponsored by Fondazione ISIDE, investigates demographics and treatment patterns of patients with immune-mediated inflam…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: A Study of LAD603 in Adults With Alopecia Areata [Phase 2]
Phase 2 clinical trial update for LAD603 in adults with alopecia areata; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants in Japan With Alopecia Areata [Phase 3]
AbbVie is conducting a Phase 3 study in Japan to evaluate the safety and effectiveness of upadacitinib tablets for alopecia areata in adults…
-
CLINICAL_TRIALS trial_result · 2025-12-11Clinical Trial Update: Tofacitinib for Immune Skin Conditions in Down Syndrome [Phase 2]
A Phase 2 trial evaluating tofacitinib for immune-mediated skin conditions in individuals with Down syndrome has completed, with results pos…
-
CLINICAL_TRIALS research · 2025-12-11Clinical Trial Update: A Study of DR-01 in Subjects With Alopecia Areata and Vitiligo [Phase 1]
Phase 1 clinical trial of DR-01 for alopecia areata and vitiligo is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-01Clinical Trial Update: Evaluate the Efficacy and Safety of Ruxolitinib on Hair Regrowth in Patients With Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED)-Associated Alopecia Areata [Phase 2]
A Phase 2 clinical trial is evaluating the efficacy and safety of ruxolitinib for hair regrowth in patients with Autoimmune Polyendocrinopat…
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: Comparison of Microneedling Along With Topical Vitamin D3 Versus Microneedling in Alopecia Areata [NA]
Clinical trial evaluating whether adding topical Vitamin D3 to microneedling improves outcomes in alopecia areata compared with microneedlin…
-
CLINICAL_TRIALS trial_result · 2025-11-21Clinical Trial Update: European Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata [Phase 3]
The European extension of the Phase 3 trial evaluating CTP-543 for alopecia areata has completed, with results posted.
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of FB102 in Patients With Severe to Very Severe Alopecia Areata. [Phase 1]
Forte Biosciences is running a Phase 1 study to evaluate the safety and efficacy of FB102 in patients with severe to very severe alopecia ar…
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: A Study to Learn About Litfulo Capsule in People With Severe Alopecia Areata in Routine Clinical Practice.
Pfizer's Litfulo (deucravacitinib) is listed as recruiting for a study to observe its use in people with severe alopecia areata in routine c…
-
CLINICAL_TRIALS trial_result · 2025-11-18Clinical Trial Update: Pre-approval Single-patient Expanded Access for Ritlecitinib (PF-06651600)
This clinical trial update reports pre-approval, single-patient expanded access for ritlecitinib (PF-06651600) in a patient with alopecia ar…
-
CLINICAL_TRIALS research · 2025-10-31Clinical Trial Update: A Phase 2a Proof-of-Concept Trial of Bempikibart (ADX-914) for the Treatment of Severe Alopecia Areata (SIGNAL-AA) [Phase 2]
A Phase 2a proof-of-concept trial evaluating Bempikibart (ADX-914) for severe Alopecia Areata is ongoing but not recruiting.
-
CLINICAL_TRIALS research · 2025-10-24Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Adult Participants With Severe Alopecia Areata [Phase 2]
A Phase 2 study is evaluating subcutaneous amlitelimab as monotherapy versus placebo in adults with severe Alopecia Areata, and the trial is…
-
CLINICAL_TRIALS trial_result · 2025-10-22Clinical Trial Update: Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata [Phase 2, Phase 3]
This document provides an update on an extension study of CTP-543 for alopecia areata. The study spans Phase 2 and Phase 3 and is currently …
-
CLINICAL_TRIALS trial_result · 2025-10-20Clinical Trial Update: HCW9302 (Interleukin-2 Fusion Protein) for Alopecia Areata [Phase 1]
HCW Biologics is recruiting for a Phase 1 trial of HCW9302, an interleukin-2 fusion protein, to treat alopecia areata.
-
CLINICAL_TRIALS trial_result · 2025-10-01Clinical Trial Update: A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata [Phase 2, Phase 3]
Phase 2/3 clinical trial results for baricitinib in participants with severe or very severe alopecia areata have been completed and results …
-
CLINICAL_TRIALS research · 2025-10-01Clinical Trial Update: A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata [Phase 3]
A Phase 3 clinical trial is evaluating two doses of ritlecitinib for alopecia areata in people aged 12 years and older, and the study is cur…
-
CLINICAL_TRIALS research · 2025-10-01Clinical Trial Update: A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata. [Phase 3]
Clinical trial update announcing a Phase 3 long-term study of ritlecitinib in children with severe alopecia areata; recruiting.